Theranos' Holmes to be sentenced in September for fraud conviction
Reuters
Published Jan 12, 2022 08:07PM ET
Updated Jan 12, 2022 08:31PM ET
By Jody Godoy
(Reuters) - Theranos founder Elizabeth Holmes is slated to be sentenced on Sept. 26 on her convictions for defrauding investors in the blood-testing startup, according to a court filing on Wednesday.
Holmes, 37, was convicted on Jan. 3 on three counts of fraud and one count of conspiring to defraud private investors in the company. She remains free on a $500,000 bond secured by properties.
Holmes plans to ask the judge overseeing her case to overturn her convictions, according to court filings. If he does not, she is likely to appeal and could seek to suspend her sentence until a final ruling.
The former entrepreneur became a Silicon Valley celebrity after claiming Theranos machines could run common blood tests on a few drops from a finger prick. Once valued at $9 billion, Theranos collapsed after the Wall Street Journal published a series of articles, starting in 2015, that suggested its devices were flawed and inaccurate.
Holmes was indicted in 2018 on allegations of defrauding investors and patients. Last week, a jury convicted her on four investor-related charges, acquitted her on four patient-related charges and deadlocked on three other counts.
Holmes had agreed with prosecutors that her sentencing should occur in September, given "ongoing proceedings in a related matter."
The trial of former Theranos executive Ramesh "Sunny" Balwani is scheduled to begin on March 9.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.